Kai Dai

Wuhan, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Research advances on gut microbiota dysbiosis and chronic liver diseases: a review.

Research advances on gut microbiota dysbiosis and chronic liver diseases: a review.

Journal: Frontiers in medicine
Published: December 10, 2025

Exosomal miR-499a-5p from human umbilical cord mesenchymal stem cells attenuates liver fibrosis via targeting ETS1/GPX4-mediated ferroptosis in hepatic stellate cells.

Exosomal miR-499a-5p from human umbilical cord mesenchymal stem cells attenuates liver fibrosis via targeting ETS1/GPX4-mediated ferroptosis in hepatic stellate cells.

Journal: Journal of nanobiotechnology
Published: October 01, 2024

Inhibition of cGAS-STING pathway by stress granules after activation of M2 macrophages by human mesenchymal stem cells against drug induced liver injury.

Inhibition of cGAS-STING pathway by stress granules after activation of M2 macrophages by human mesenchymal stem cells against drug induced liver injury.

Journal: Molecular immunology
Published: July 08, 2023

Advancements in mesenchymal stem cell therapy for liver cirrhosis: Unveiling origins, treatment mechanisms, and current research frontiers.

Advancements in mesenchymal stem cell therapy for liver cirrhosis: Unveiling origins, treatment mechanisms, and current research frontiers.

Journal: Tissue & cell
Published: April 27, 2023

Human umbilical cord-derived mesenchymal stromal cells alleviate liver cirrhosis through the Hippo/YAP/Id1 pathway and macrophage-dependent mechanism.

Human umbilical cord-derived mesenchymal stromal cells alleviate liver cirrhosis through the Hippo/YAP/Id1 pathway and macrophage-dependent mechanism.

Journal: International immunopharmacology
Published: April 13, 2023

Impact of inflammation and the immune system on hepatocellular carcinoma recurrence after hepatectomy.

Impact of inflammation and the immune system on hepatocellular carcinoma recurrence after hepatectomy.

Journal: Cancer medicine
Published: April 05, 2023

IGF2-NR4A2 Signaling Regulates Macrophage Subtypes to Attenuate Liver Cirrhosis.

IGF2-NR4A2 Signaling Regulates Macrophage Subtypes to Attenuate Liver Cirrhosis.

Journal: Journal of clinical and translational hepatology
Published: August 11, 2022

Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer.

Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer.

Journal: Frontiers in oncology
Published: April 18, 2022

Mesenchymal stromal cells: promising treatment for liver cirrhosis.

Mesenchymal stromal cells: promising treatment for liver cirrhosis.

Journal: Stem cell research & therapy
Published: February 20, 2022

Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinoma.

Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinoma.

Journal: World journal of gastrointestinal oncology
Published: February 20, 2021

Clinical characteristics and risk factors for in-hospital mortality of lung cancer patients with COVID-19: A multicenter, retrospective, cohort study.

Clinical characteristics and risk factors for in-hospital mortality of lung cancer patients with COVID-19: A multicenter, retrospective, cohort study.

Journal: Thoracic cancer
Published: September 02, 2020

Clinical characteristics and outcomes of cancer patients with COVID-19.

Clinical characteristics and outcomes of cancer patients with COVID-19.

Journal: Journal of medical virology
Published: April 27, 2020
Showing 1-12 of 19

Last Updated: 09/26/2026